Comparison of response rate estimators of anti-cancer drugs in two-stage designs
From MaRDI portal
Publication:3635375
zbMATH Open1190.62189MaRDI QIDQ3635375FDOQ3635375
Authors: Shigeyuki Toyoizumi, Chikuma Hamada, Isao Yoshimura 
Publication date: 6 July 2009
Recommendations
- Some results on estimation for two—stage clinical trials
- Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials
- Conditional Estimation in Two-Stage Adaptive Designs
- An assessment of up- and down designs and associated estimators in phase I trials
- Design and Analysis of Phase II Cancer Trials: A Review of Statistical Methods and Guidelines for Medical Researchers
Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
This page was built for publication: Comparison of response rate estimators of anti-cancer drugs in two-stage designs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3635375)
